Investigational herpes zoster vaccine is safe, effective in older adults with prior infection

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • An adjuvanted recombinant subunit herpes zoster vaccine (Hz/su) was found safe and immunogenic in adults aged ≥50 y with a prior history of herpes zoster infection documented by a physician.

Why this matters

  • The patient population, older adults with prior history of herpes z...